Hamostaseologie 1985; 05(03): 108-115
DOI: 10.1055/s-0038-1655110
Originalarbeiten
Schattauer GmbH

Alveoläre Surfactant-Funktion und Gerinnung

W. Seeger
1   Klinische Pathophysiologie und Experimentelle Medizin am Zentrum für Innere Medizin (Prof. Dr. Dr. h.c. H. G. Lasch), Justus-Liebig-Universität Gießen
,
H. Neuhof
1   Klinische Pathophysiologie und Experimentelle Medizin am Zentrum für Innere Medizin (Prof. Dr. Dr. h.c. H. G. Lasch), Justus-Liebig-Universität Gießen
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

 

 
  • LITERATUR

  • 1 Balis J. U, Shelley S. A, McCue M. J, Rappaport E. S. Mechanisms of damage to the lung surfactant system. Exp. Mol. Pathol. 14: 243-262 1971;
  • 2 Benson B. J, Williams M. C, Haw-good S, Sargeant T. Role of lung surfactant- specific proteins in surfactant structure and function. Prog. Resp. Res. 18: 83-92 1984;
  • 3 Bernaudin J. F, Bignon J. Permeability of the air-blood barrier to macromolecules. Ann. Anesthesiol. Fr. 21: 629-633 1980;
  • 4 Bleyl U, Heilmann K, Adler D. Generalisierte plasmatische Hypercoagulabilität und pulmonale hyaline Membranen beim Erwachsenen. Klin. Wschr. 49: 71-81 1971;
  • 5 Bleyl U, Büsing C. M. Zur Pathogenese der urämischen Pneumonitis. Klin. Wschr. 56: 121-134 1978;
  • 6 Bredenberg C. E, Paskanik A. M, Nieman G. F. High surface tension pulmonary edema. J. Surg. Res. 34: 515-523 1983;
  • 7 Bredenberg C. E, Nieman G. F. role of Surfactant in the pathogenesis of pulmonary edema, RDS and ARDS. Prog. Resp. Res. 18: 187-192 1984;
  • 8 Clements J. A, Hustead R. F, Johnson R. P, Gribetz I. Pulmonary surface tension and alveolar stability. J. appl. Physiol. 16: 444-450 1961;
  • 9 Drinker C. K, Warren M. F, McLa-nahan M. The absorption of protein solutions from the pulmonary alveoli. J. Exp. Med. 66: 449-458 1937;
  • 10 Hallman M, Feldmann B. H, Kirkpatrick E, Gluck L. Absence of phosphatidyl- glycerol (PG) in the respiratory distress syndrome in the newborn. Pediatr. Res. 11: 714-719 1977;
  • 11 Higuchi M, Hirano H, Maki M. The thromboplastic activity of lung surfactant in amniotic fluid and its application to prenatal assessment of fetal lung maturity. Tohoku J. Exp. Med. 133: 267-273 1981;
  • 12 Ikegami M, Jobe A, Glatz T. Surface activity following natural surfactant treatment in premature lambs. J. appl. Physiol. 51: 306-312 1981;
  • 13 Jobe A, Ikegami M, Jacobs H, Jones S, Conaway D. Permeability of premature lamb lungs to protein and the effect of surfactant on that permeability. J. appl. Physiol. 55: 169-176 1983;
  • 14 King R. J, MacBeth M. C. Interaction of the lipid and protein components of pulmonary surfactant. Role of phosphatidylglyce- rol and calcium. Biochim. Biophys. Acta. 647: 159-168 1981;
  • 15 King R. J. The apolipoproteins of pulmonary surfactant. Prog. Resp. Res. 18: 68-82 1984;
  • 16 Neergard V. K. Neue Auffassung über einen Grundbegriff der Atemmechanik. Z. ges. exp. Med. 66: 373-383 1929;
  • 17 Paciga J. E, Shelley S. A, Balis J. U. Secretory IgA is a component of rabbit lung surfactant. Biochim. Biophys. Acta. 631: 487-494 1980;
  • 18 Said S. I, Avery M. E, Davis R. K, Banerjee C. M, El-Gohary M. Pulmonary surface activity in induced pulmonary edema. J. Clin. Invest 44: 458-464 1965;
  • 19 Seeger W, Wolf H, Stähler G, Neuhof H. Increased pulmonary vascular resistance and permeability due to arachidonate metabolism in isolated rabbit lungs. Prostaglandins 23: 157-173 1982;
  • 20 Seeger W, Wolf H, Stähler G, Neuhof H. Alteration of pressure-volume characteristics due to different types of edema induction in isolated rabbit lungs. Respira. 44: 273-281 1983;
  • 21 Seeger W, Stöhr G, Wolf H, Neuhof H. Alteration of surfactant function due to protein leakage: special interaction with fibrinmonomer. J. appl. Physiol. 58: 326-338 1985;
  • 22 Shelley S. A, Balis J. U, Paciga J. E, Espinoza C. G, Richman A. V. Biochemical composition of adult human lung surfactant. Lung. 160: 195-206 1982;
  • 23 Sueishi K, Benson B. J. Isolation of a major apolipoprotein of canine and murine pulmonary surfactant. Biochemical and immunochemical characteristics. Biochim. Biophys. Acta. 665 (03) 442-453 1981;
  • 24 Taylor F. B, Abrams M. E. Effect of surface active lipoprotein on clotting and fibrinolysis, and of fibrinogen on surface tension of surface active lipoprotein. Am. J. Med. 40: 346-350 1966;
  • 25 Tierney D. F, Johnson R. P. Altered surface tension of lung extracts and lung mechanics. J. Appl. Physiol. 20: 1253-1260 1965;
  • 26 Yu S, Harding P. G, Smith N, Possmayer FBovine, surfactant pulmonary. chemical composition and physical properties. Lipids 18: 522-529 1983;